These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31838949)

  • 1. The treatment outcome of chronic HBV infection among HBV/HIV co-infected and HBV mono-infected patients.
    Karić U; Milošević I; Pešić-Pavlović I; Salemović D; Stojković M; Jevtović D
    Int J STD AIDS; 2020 Jan; 31(1):38-45. PubMed ID: 31838949
    [No Abstract]   [Full Text] [Related]  

  • 2. Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients.
    Coffin CS; Osiowy C; Myers RP; Gill MJ
    J Clin Virol; 2013 Jun; 57(2):103-8. PubMed ID: 23465393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Patients co-infected with HIV and hepatitis-B virus (HBV): the favourable effect of lamivudine, as part of combined antiretroviral therapy, on HBV may be dependent upon the number of CD4-cells].
    Smit MC; Haverkamp MH; Weersink AJ; Boucher CA; Hoepelman IM
    Ned Tijdschr Geneeskd; 2004 Nov; 148(47):2330-4. PubMed ID: 15587052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort.
    Ladep NG; Agaba PA; Agbaji O; Muazu A; Ugoagwu P; Imade G; Cooke G; McCormack S; Taylor-Robinson SD; Idoko J; Kanki P
    World J Gastroenterol; 2013 Mar; 19(10):1602-10. PubMed ID: 23538773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric HIV-HBV Coinfection in Lusaka, Zambia: Prevalence and Short-Term Treatment Outcomes.
    Peebles K; Nchimba L; Chilengi R; Bolton Moore C; Mubiana-Mbewe M; Vinikoor MJ
    J Trop Pediatr; 2015 Dec; 61(6):464-7. PubMed ID: 26338421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia.
    Vinikoor MJ; Sinkala E; Chilengi R; Mulenga LB; Chi BH; Zyambo Z; Hoffmann CJ; Saag MS; Davies MA; Egger M; Wandeler G;
    Clin Infect Dis; 2017 May; 64(10):1343-1349. PubMed ID: 28158504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy.
    Malagnino V; Cerva C; Maffongelli G; Teti E; Foroghi Biland L; Cesta N; De Masi M; Stingone C; Armenia D; Svicher V; Salpini R; Andreoni M; Sarmati L
    Sci Rep; 2019 Aug; 9(1):11942. PubMed ID: 31420570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
    Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
    Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study.
    Wandeler G; Gsponer T; Bihl F; Bernasconi E; Cavassini M; Kovari H; Schmid P; Battegay M; Calmy A; Egger M; Furrer H; Rauch A;
    J Infect Dis; 2013 Nov; 208(9):1454-8. PubMed ID: 23901088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hepatitis B virus (HBV) surface-gene variability on markers of replication during treated human immunodeficiency virus-HBV infection in Western Africa.
    Boyd A; Moh R; Maylin S; Abdou Chekaraou M; Mahjoub N; Gabillard D; Anglaret X; Eholié SP; Danel C; Delaugerre C; Zoulim F; Lacombe K;
    Liver Int; 2019 Feb; 39(2):280-289. PubMed ID: 30257068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
    Stephan C; Berger A; Carlebach A; Lutz T; Bickel M; Klauke S; Staszewski S; Stuermer M
    J Antimicrob Chemother; 2005 Dec; 56(6):1087-93. PubMed ID: 16269552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing.
    Audsley J; Littlejohn M; Yuen L; Sasadeusz J; Ayres A; Desmond C; Spelman T; Lau G; Matthews GV; Avihingsanon A; Seaberg E; Philp F; Saulynas M; Ruxrungtham K; Dore GJ; Locarnini SA; Thio CL; Lewin SR; Revill PA
    Virology; 2010 Sep; 405(2):539-47. PubMed ID: 20655563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus-Hepatitis B Virus Co-infected Patients from Sub-Saharan Africa.
    Boyd A; Houghtaling L; Moh R; Chekaraou MA; Gabillard D; Eholié SP; Anglaret X; Zoulim F; Danel C; Lacombe K; For The Anrs Trivacan And Anrs VarBVA Studies
    Am J Trop Med Hyg; 2017 Dec; 97(6):1936-1942. PubMed ID: 29141712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe.
    Soriano V; Mocroft A; Peters L; Rockstroh J; Antunes F; Kirkby N; de Wit S; Monforte Ad; Flisiak R; Lundgren J;
    J Antimicrob Chemother; 2010 Mar; 65(3):548-55. PubMed ID: 20051475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity.
    Audsley J; Bent SJ; Littlejohn M; Avihingsanon A; Matthews G; Bowden S; Bayliss J; Luciani F; Yuen L; Fairley CK; Locarnini S; Lewin SR; Sasadeusz J
    AIDS; 2016 Jun; 30(10):1597-606. PubMed ID: 26950313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of Hepatitis B Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in the TREAT Asia Pediatric HIV Observational Database.
    Aurpibul L; Kariminia A; Vibol U; Fong MS; Le ON; Hansudewechakul R; Bunupuradah T; Kurniati N; Chokephaibulkit K; Kumarasamy N; Wati DK; Yusoff NKN; Razali KAM; Nallusamy RA; Sohn AH; Lumbiganon P;
    Pediatr Infect Dis J; 2018 Aug; 37(8):788-793. PubMed ID: 29846357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?
    Rana U; Driedger M; Sereda P; Pan S; Ding E; Wong A; Walmsley S; Klein M; Kelly D; Loutfy M; Thomas R; Sanche S; Kroch A; Machouf N; Roy-Gagnon MH; Hogg R; Cooper CL;
    BMC Infect Dis; 2019 Nov; 19(1):982. PubMed ID: 31752729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
    J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral treatment for human immunodeficiency virus patients co-infected with hepatitis B virus: combined effect for both infections, an obtainable goal?
    Wolters LM; Niesters HG; de Man RA; Schalm SW
    Antiviral Res; 1999 May; 42(1):71-6. PubMed ID: 10333144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment.
    Singh KP; Crane M; Audsley J; Avihingsanon A; Sasadeusz J; Lewin SR
    AIDS; 2017 Sep; 31(15):2035-2052. PubMed ID: 28692539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.